Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.
2.

Human papillomavirus in cervical cancer screening: important role as biomarker.

Boulet GA, Horvath CA, Berghmans S, Bogers J.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):810-7. doi: 10.1158/1055-9965.EPI-07-2865. Review.

3.

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.

Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/78-89. Review.

PMID:
16950021
4.

Cervical cancer screening in the 21st century: is it time to retire the PAP smear?

Wright TC Jr.

Clin Obstet Gynecol. 2007 Jun;50(2):313-23. Review.

PMID:
17513921
5.

HPV testing in cervical screening.

Brink AA, Snijders PJ, Meijer CJ, Berkhof J, Verheijen RH.

Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):253-66. Epub 2005 Dec 13. Review.

PMID:
16359926
6.

Human papillomavirus testing for primary cervical cancer screening.

Grce M, Davies P.

Expert Rev Mol Diagn. 2008 Sep;8(5):599-605. doi: 10.1586/14737159.8.5.599. Review.

PMID:
18785808
8.

Screening of cervical cancer: where do we go from here?

Kuo DY, Goldberg GL.

Cancer Invest. 2003;21(1):157-61. Review. No abstract available.

PMID:
12643017
9.

The role of self-collection devices for cytology and human papillomavirus DNA testing in cervical cancer screening.

Bidus MA, Zahn CM, Maxwell GL, Rodriguez M, Elkas JC, Rose GS.

Clin Obstet Gynecol. 2005 Mar;48(1):127-32. Review. No abstract available.

PMID:
15725865
10.

Human papillomavirus and cervical cancer screening. Recent advances improve the clinical picture.

Berman NR.

Adv Nurse Pract. 2002 Oct;10(10):26-35; quiz 35-6. Review. No abstract available.

PMID:
12424881
11.

Update on pathophysiologic mechanisms of human papillomavirus.

Moodley M.

Curr Opin Obstet Gynecol. 2005 Feb;17(1):61-4. Review.

PMID:
15711413
12.

[New ways of cervical cancer screening].

Teikari M.

Duodecim. 2004;120(13):1595-6; discussion 1596-7. Review. Finnish. No abstract available.

PMID:
15326967
13.

Emerging technology in cervical cancer screening: status of molecular markers.

Padilla-Paz LA.

Clin Obstet Gynecol. 2005 Mar;48(1):218-25. Review. No abstract available.

PMID:
15725874
14.

FHACT: the FISH-based HPV-associated cancer test that detects nonrandom gain at four genomic loci as biomarkers of disease progression.

Houldsworth J.

Expert Rev Mol Diagn. 2014 Nov;14(8):921-34. doi: 10.1586/14737159.2014.965685. Epub 2014 Oct 11. Review.

PMID:
25308338
15.

Current cervical screening technology considerations: liquid-based cytology and automated screening.

Russell J, Crothers BA, Kaplan KJ, Zahn CM.

Clin Obstet Gynecol. 2005 Mar;48(1):108-19. Review. No abstract available.

PMID:
15725863

Supplemental Content

Support Center